AI

Microsoft and NVIDIA: Accelerating physical AI at scale Physical AI cannot be delivered through point solutions. It requires agentic-driven, enterprise-grade development, deployment, and operations toolchains and …

Artificial intelligence (AI) will help the drug industry automate aspects of biopharmaceutical process development, but human oversight will always be a necessity, according to new analysis. …

Ten years ago AlphaGo, Google DeepMind’s AI program, stunned the world by defeating the South Korean Go player Lee Sedol. And in the years since, AI …

Novartis will apply Unnatural Products (UNP)’s artificial intelligence (AI)-guided macrocyclic peptide platform to develop next-generation cardiovascular disease therapeutics, through a collaboration that could generate more than …

Cherepanov and Strýček were confident that their discovery, which they dubbed PromptLock, marked a turning point in generative AI, showing how the technology could be exploited …

A study released by Google Cloud late last year offered some eye-opening insights into where life sciences and healthcare executives are using artificial intelligence (AI), where …

Civitai automatically tags bounties requesting deepfakes and lists a way for the person featured in the content to manually request its takedown. This system means that …

2026 kicked off with a stream of AI platform deals across pharma, signaling a cultural shift away from single-asset bets and toward investment in AI infrastructure for broad discovery.   The collaborations between AI start-ups, Chai Discovery, Noetik, …

CES, the Consumer Electronics Show, is the world’s biggest tech show, where companies launch new gadgets and announce new developments, and it happens every January. This …

A German automated laboratory may herald the future of less expensive pharmaceutical drugs thanks to the latest developments in computer-controlled robotics and bioinformatics. Scientists at the …